Brand Reference: Wellbutrin XL
| Metric | Verified Benchmark | Source |
|---|---|---|
| Bupropion Hydrochloride 24-Hour XL RxNorm Concept ID | 42347 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0950 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $64.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $6.80 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $8.50 / mo | 68 Zero-PHI Verified Patient Logs |
Devoid of serotonergic, histaminergic, or anticholinergic activity; inhibits norepinephrine (NET) and striatal/prefrontal dopamine (DAT) reuptake largely via its active hydroxybupropion metabolite—reversing anhedonia, fatigue, and SSRI-induced sexual dysfunction with slight weight loss.
Classified under Norepinephrine-Dopamine Reuptake Inhibitor (NDRI) & Nicotinic Antagonist (Rx), Bupropion Hydrochloride 24-Hour XL exhibits a $57.20/month gap between standard U.S. retail cash counters ($64.00) and verified direct-to-patient routing ($6.80) anchored to $0.0950 CMS unit cost.
Pharmacokinetic profiling of Bupropion Hydrochloride 24-Hour XL demonstrates an elimination half-life of 21 hours parent / 20 hours hydroxybupropion / 37 hours threohydrobupropion with ~70% hydrogel matrix XL systemic bioavailability; clearance proceeds via hepatic cyp2b6 hydroxylation; strong cyp2d6 inhibitor, reaching clinical onset within 1–2 weeks energy/focus lift; 4 weeks mood full effect.
Titration schedules for Bupropion Hydrochloride 24-Hour XL (150 mg XL PO QAM → 300 mg XL PO QAM → 450 mg XL PO QAM (strict single-dose ceiling)) require excluding seizure disorder; current or prior anorexia nervosa or bulimia (electrolyte seizure risk); abrupt alcohol or benzodiazepine withdrawal; maoi within 14 days; real-world patient logs highlight dry mouth (22% of reports), honeymoon insomnia weeks 1–2 (21% of reports), heightened caffeine sensitivity (18% of reports) alongside a 91.70% Worth-It consensus.
Across 68 verified cash-pay logs, Bupropion Hydrochloride 24-Hour XL achieves a 91.70% Worth-It rating with out-of-pocket spend averaging $8.50/mo versus $64.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 150 mg XL PO QAM for Bupropion Hydrochloride 24-Hour XL; monthly out-of-pocket dropped to $5.98 compared with $64.00 retail.
Completed 10 weeks on Bupropion Hydrochloride 24-Hour XL (300 mg XL PO QAM). Zero notable side effects on steady dosing.
Consistent biomarker response on 450 mg XL PO QAM (strict single-dose ceiling) Bupropion Hydrochloride 24-Hour XL sourced via Cost Plus Drugs ($7.89/mo cash pay without insurance prior authorization).